NATIONAL OXYGEN LTD.

Price

57.28

-4.22%
O:59.8
H:60.86
L:57
C:57.28

52W Range

42.5132.5
+35%/-57%

Market Cap

0 Cr

Traded: ₹0.02 Cr (Infinity%) 0.0x

Volume · 60D trend

3.59 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:+1% 3M:-3% 6M:-18% 12M:-40%

Valuation

P/E--
P/B--
P/S--
EV/EBIT-27.6

Business Strength

ROE0.0%
ROCE-21.5%
OPM-14.5%
NPM8.0%

Growth (3Y CAGR)

EPS+126.3%
Sales-21.0%
Profit--
3Y Return-6.0%

Balance Sheet

Debt/Equity-4.7
Debt28.6 Cr
Pledge0.0%
CWIP/Fixed Asset17.9%

Cash Position

CFO/NP-59.2%
FCF3.11 Cr
FCF 3Y Avg-0.15 Cr
Cash/MCap2.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle28.3 days
Tradeable Free Float19.4%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
--
--
--
--
--
Sales
-4.0%
-10.0%
-21.0%
--
-43.0%
Decelerating
Profit
-1.0%
--
--
--
+10.0%
Accelerating
Return
+6.0%
+3.0%
-6.0%
-43.0%
--
Decelerating

Quarterly Results

Mar 2026

PDF
Rev
4 Cr
-54% YoY-21% QoQ
OPM-27.7%
NPM-44.8%
PAT
+31% YoY-2 Cr
EPS
+31% YoY-3.5

Dec 2025

PDF
Rev
5 Cr
-53% YoY-21% QoQ
OPM-14.5%
NPM-30.8%
PAT
+22% YoY-2 Cr
EPS
+22% YoY-3.1

Sep 2025

PDF
Rev
6 Cr
-40% YoY-16% QoQ
OPM-7.1%
NPM110.5%
PAT
+9% YoY7 Cr
EPS
+692% YoY14.0

Jun 2025

PDF
Rev
8 Cr
-28% YoY-12% QoQ
OPM-13.6%
NPM-24.7%
PAT
-50% YoY-2 Cr
EPS
-50% YoY-3.7

Mar 2025

PDF
Rev
9 Cr
-22% YoY-20% QoQ
OPM-20.6%
NPM-30.1%
PAT
-208% YoY-3 Cr
EPS
-208% YoY-5.1

Dec 2024

PDF
Rev
11 Cr
-5% YoY+2% QoQ
OPM-7.0%
NPM-18.4%
PAT
-64% YoY-2 Cr
EPS
-56% YoY-3.9

Sep 2024

PDF
Rev
11 Cr
-10% YoY+0% QoQ
OPM0.6%
NPM-11.2%
PAT
-98% YoY-1 Cr
EPS
-89% YoY-2.4

Jun 2024

PDF
Rev
11 Cr
-5% YoY-4% QoQ
OPM0.0%
NPM-11.8%
PAT
-116% YoY-1 Cr
EPS
-105% YoY-2.5

Mar 2024

PDF
Rev
11 Cr
-9% YoY-2% QoQ
OPM2.1%
NPM-7.6%
PAT
-200% YoY-1 Cr
EPS
-195% YoY-1.7

Dec 2023

PDF
Rev
11 Cr
---4% QoQ
OPM-0.2%
NPM-10.7%
PAT
-152% YoY-1 Cr
EPS
---2.5

Sep 2023

PDF
Rev
12 Cr
--+6% QoQ
OPM4.2%
NPM-5.1%
PAT
+49% YoY-1 Cr
EPS
---1.3

Jun 2023

PDF
Rev
11 Cr
---8% QoQ
OPM4.8%
NPM-5.2%
PAT
-3000% YoY-1 Cr
EPS
---1.2

Mar 2023

PDF
Rev
12 Cr
----
OPM14.3%
NPM6.9%
PAT
-14% YoY1 Cr
EPS
--1.8

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity-4.69
Interest Coverage-0.9x
Promoter Pledge0.0%
Borrowings29 Cr

Efficiency

Receivable Days28.3 days
Inventory Days days
Payable Days days
Cash Conversion cycle28.3 days

Cash Position

Operating Cash Flow-1 Cr
Investing Cash Flow5 Cr
Financing Cash Flow-3 Cr
Free Cash Flow3 Cr

Detailed Financials

Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023PDF ↗
Jun 2023PDF ↗
Mar 2023PDF ↗
Sales456891111111111121112
Expenses5679101211111111111110
Operating Profit-1-1-0-1-2-1000-0112
OPM %-27.7%-14.5%-7.1%-13.6%-20.6%-7.0%0.6%0.0%2.1%-0.2%4.2%4.8%14.3%
Other Income0080000000000
Interest0000000000000
Depreciation1111111111111
Profit Before Tax-2-27-2-3-2-1-1-1-1-1-11
Tax %0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit-2-27-2-3-2-1-1-1-1-1-11
Exceptional Items0080000000000
EPS (Rs)-3.5-3.114.0-3.7-5.1-3.9-2.4-2.5-1.7-2.5-1.3-1.21.8
Sales Growth (YoY)-53.9%-53.3%-40.0%-28.3%-21.8%-4.6%-10.2%-5.0%-8.9%--------
Sales Growth (QoQ)-21.2%-20.9%-16.0%-12.1%-20.0%1.6%0.4%-4.1%-2.5%-4.3%6.2%-8.1%--
OP Growth (YoY)38.2%3.9%-850.0%---873.9%-3700.0%-88.0%-100.0%-86.7%--------
OP Growth (QoQ)-50.7%-62.2%56.3%42.1%-134.2%-1366.7%---100.0%1250.0%-104.0%-5.7%-69.4%--
Profit Growth (YoY)31.3%21.7%9.2%-49.6%-208.3%-63.6%-98.3%-115.5%-200.0%-152.1%48.7%-3000.0%-14.3%
EPS Growth (YoY)31.3%21.9%691.5%-49.6%-207.8%-56.0%-88.8%-105.0%-195.4%--------
EPS Growth (QoQ)-15.0%-122.0%476.3%27.8%-30.8%-66.5%4.8%-48.5%33.7%-101.6%-3.3%-169.1%--
OP Margin-27.7%-14.5%-7.1%-13.6%-20.6%-7.0%0.6%0.0%2.1%-0.2%4.2%4.8%14.3%
Net Margin-44.8%-30.8%110.5%-24.7%-30.1%-18.4%-11.2%-11.8%-7.6%-10.7%-5.1%-5.2%6.9%
Material Cost %-2.8%4.4%0.3%-0.4%-0.5%1.3%-0.4%-0.1%-0.2%1.1%0.8%-1.1%-0.2%
Employee Cost %16.1%12.3%9.9%10.6%9.6%7.8%7.6%8.0%7.6%7.4%6.5%7.8%6.6%
P/S--------------------------
P/E--------------------------
P/B--------------------------

Shareholding Pattern

Shareholders:5.0K (+6.9%)
Current MixMar 2026

Exchange Filings

50
Result12 Aug 2026

The Board of Directors of the Company at its meeting held today, i.e. Wednesday, 12th August, 2026 approved the Unaudited Financial Results of the Company for the quarter ended 30th June, ....

Board Meeting12 Aug 2026

Pursuant to Regulation 30 and 33 of the SEBI (LODR) Regulations, 2015, we wish to inform you that, the Board of Directors of the Company at its meeting held today, i.e. on Wednesday, 12th ....

Company Update08 Aug 2026

Submission of Newspaper Advertisement for the 51st Annual General Meeting (AGM) of the Company to be held on Friday, 28th August, 2026 at 11:30 A.M IST through Video Conferencing

Board Meeting08 Aug 2026

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

Others06 Aug 2026

Submission of 51st Annual report of the company for the Financial Year 2025-26.

Corp. Action06 Aug 2026

The Register and Books of Accounts shall be closed from 22nd August 2026 to 28th August 2026. (Inclusive of both days)

AGM/EGM06 Aug 2026

Submission of Notice of 51st AGM to be held on 28.08.2026

Board Meeting04 Aug 2026

1. The Notice of the 51st Annual General Meeting to be held on Friday, 28th day of August 2026 at 11.30 A.M. through video conference, 2. The Annual Report including Director's Report and ....

Company Update15 Jul 2026

Intimation regarding withdrawal of Proposed Preferential issue of Equity Shares

Others15 Jul 2026

Withdrawal of Preferential Issue

Company Update08 Jul 2026

Submission of Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30.06.2026

Insider Trading / SAST03 Jul 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hitesh Ramji Javeri & PACs

Insider Trading / SAST02 Jul 2026

The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajesh Kumar Saraf

Insider Trading / SAST01 Jul 2026

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for

Company Update01 Jul 2026

Submission of Sale of Shares by the Promoter ( Form - C ) , PIT Regulations

Company Update29 Jun 2026

Submission of disclosure of Sale of Shares by the Promoter ( Form - C ) PIT Regulations

Insider Trading / SAST25 Jun 2026

Intimation of trading window closure for the quarter ended 30th June 2026

Company Update24 Jun 2026

Submission of disclosure of sale of share by the Promoter ( Form-C ) - PIT Regulations

Company Update22 Jun 2026

Submission of disclosure of sale of shares by the Promoters ( FORM - C ) - PIT Regulations

AGM/EGM29 May 2026

Submission of Scrutinizer Report for the EGM held on 28th May 2026

AGM/EGM28 May 2026

Submission of Proceedings of EGM held on 28th May 2026

Result25 May 2026

Submission of Financial Results for the quarter & year ended 31st March 2026

Company Update25 May 2026

Submission of Regulation 23(9) of SEBI (LODR) 2015 - Non - Applicability certificate

Board Meeting25 May 2026

1. Approval of Audited Financial Results 2. Approval of appointment of Internal Auditor

Board Meeting19 May 2026

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to consider and approve the Audited Financial Results ....

Company Update13 May 2026

Submission of Newspaper Publication for dispatch of EGM notice dated 29th April 2026

Corp. Action06 May 2026

The Register of members & share transfer books of the Company will remain closed from 22nd May 2026 to 28th May 2026

AGM/EGM06 May 2026

Increase in Authorized Share Capital Issue of 9,50,000 shares on Preferential basis

Company Update29 Apr 2026

Issue of 9,50,000 Shares on Preferential basis

Board Meeting29 Apr 2026

The increase in the Authorized Share Capital of the Company from Rs. 17,10,00,000 (Rupees Seventeen Crores Ten Lakhs only) to Rs. 18,10,00,000 (Rupees Eighteen Crores Ten Lakhs only). ....

Board Meeting24 Apr 2026

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2026 ,inter alia, to consider and approve a) Fixation of relevant date ....

Company Update17 Apr 2026

Clarification to announcement filed on 13th of April 2026

Company Update15 Apr 2026

Submission of Intimation of Disclosure of Non-Identification as a Large Corporate Entity

Company Update13 Apr 2026

Demise of Mr. Gajanand Saraf ( DIN : 00007320 ) , Whole Time Director of the Company

Company Update13 Apr 2026

Submission of Certificate under Regulation 74(5) of SEBI ( DP ) Regulation 2018

Insider Trading / SAST26 Mar 2026

Intimation of Closure of Trading Window as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 for the quarter and financial year ending 31st March, 2026

Company Update20 Mar 2026

Issue of up to 9,50,000 (Nine Lakh Fifty Thousand) Equity Shares, having a face value of Rs.10/- (Rupees Ten Only) each, at a price not less than the price determined in accordance with ....

Board Meeting20 Mar 2026

The Board of Directors of the Company at its meeting held today i.e, on Friday, March 20, 2026 have inter alia approved the following: a) Issue of up to 9,50,000 (Nine Lakh Fifty Thousand) ....

Board Meeting17 Mar 2026

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/03/2026 ,inter alia, to consider and approve Preferential Issue of Equity Shares.

Result30 Jan 2026

Submission of unaudited results for the quarter ended 31st December 2025

Board Meeting30 Jan 2026

The Unaudited financial results along with the limited review report for the quarter ended 315t December 2025.

Board Meeting27 Jan 2026

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve the unaudited Financial Results ....

Insider Trading / SAST27 Jan 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for F L Dadabhoy & Others

Company Update12 Jan 2026

Submission of Compliance Certificate as per Regulation 74(5) of SEBI(DP) Regulations , 2018 for the quarter ended 31st December 2025

Insider Trading / SAST25 Dec 2025

Intimation of Closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015 for the quarter ending on 31st December, 2025

Company Update20 Nov 2025

Newspaper Publication for the quarter ended 30.09.2025

Company Update12 Nov 2025

Submission of 23(9) - Non applicability Certificate

Result12 Nov 2025

Submission of Financial Results for the quarter ended 30th September 2025

Board Meeting12 Nov 2025

The Unaudited financial results along with the limited review report for the quarter / Half Year ended 30th September 2025.

Board Meeting06 Nov 2025

National Oxygen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve the unaudited results for the ....

Annual Reports

15

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011